Back

Hypophosphatemia in HFrEF patients after iron supplementation. Ferric carboxymaltose vs Ferric derisomaltose

11 May 2024 (14:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pathophysiology and mechanisms 9 Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Noel Panagiotides

Medical University of Vienna, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail
Predictors and long-term clinical impact of heart failure with improved ejection fraction after acute myocardial infarction
Doctor S. Kim (Seongnam, KR)
Abstract Slides Video
Presentation thumbnail
Right ventricular-arterial coupling is a strong and independent predictor of impaired exercise tolerance in heart failure with reduced ejection fraction
Doctor G. Guida (San Donato Milanese, IT)
Abstract Slides Video
Presentation thumbnail
Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction
Doctor O. Otero Garcia (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
A preclinical feasibility study employing machine learning for the prediction of left ventricle pressure indices
Doctor F. Lo Muzio (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Cost-effectiveness of quadruple therapy for heart failure with reduced ejection fraction (HFrEF) in Spain
Doctor J. Parrondo (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - pathophysiology and mechanisms 9

The Event

Event poster

Heart Failure 2024

11 May 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Ferric carboxymaltose modulates metabolic and inflammatory pathways alongside erythropoiesis in heart failure: mechanistic insights from the AFFIRM-AHF
thumbnail
Congress Presentation
Iron therapy
thumbnail
Congress Presentation
Treatment of iron deficiency in heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources